baber/WOPTO huggingface dataset:
Patent JP-4805445-B2 (JP)
IPC: B23Q3/18
Filed: 2000-07-10
Granted: 2011-11-02
Abstract: The unit (1) has a chuck (1) to clamp a work piece support, with a centring pin (22) on the chuck co-operating with second positioning devices on the work piece support. The pin and second positioning devices co-operate in pairs as alignment elements and position the work piece support in three orthogonal axes and the desired angle. A clamp device (12,18) fixes the clamping force of the work piece support in position at the chuck. The clamp device has a number of clamping balls (18) and an annular groove. The line of the clamping force of the clamp device lies in a cylindrical casing surface (MF) of the chuck, which is parallel the chuck axis (Z) and intersects the centring pin and second positioning devices.
Patent JP-3913965-B2 (JP)
IPC: A61P35/00
Filed: 2000-07-28
Granted: 2007-05-09
Abstract: A reconstituted human antibody against a human interleukin 6 receptor (IL-6R), which is composed of: (A) an L chain composed of (1) the C region of a human L chain and (2) the V region of an L chain comprising the framework region (FR) of a human L chain and the complementarity-determining region (CDR) of the L chain of a mouse monoclonal antibody against a human IL-6R, and (B) an H chain composed of (1) the C region of a human H chain and (2) the V region of an H chain comprising the FR of a human H chain and the CDR of the H chain of a mouse monoclonal antibody against a human IL-6R. Since most of the reconstituted human antibody originates in human antibodies and the CDR is lowly antigenic, this antibody is lowly antigenic against human and hence prospective as a therapeutic agent.   <IMAGE>
Patent JP-3601432-B2 (JP)
IPC: H01L25/04
Filed: 2000-10-04
Granted: 2004-12-15
Abstract: PROBLEM TO BE SOLVED: To provide a semiconductor device which reduces the concentration of stress on a bonding member connecting a semiconductor chip and a conductor member due to thermal stress. SOLUTION: An E heat sink 3 is bonded by solder to the top surfaces 1a and 2a of semiconductor chips 1 and 2, a 2nd conductor 5 is bonded by solder 4 to the backsides 1b and 2b, and a 3rd conductor member 6 is bonded by solder to the top surface 3a of the E heat sink 3. The E heat sink 3 is provided with a step part 3c to have a thin part 3d, and the bonding area between the E heat sink 3 and 3rd semiconductor member 6 is smaller than that between the E heat sink 3 and semiconductor chips 1 and 2. The respective members 1 to 8 are sealed with resin so that the backside 5b of the 2nd conductor member 5 and the top surface 6a of the 3rd conductor member 6 are exposed.
Patent JP-4068802-B2 (JP)
IPC: C07D405/12
Filed: 2000-12-01
Granted: 2008-03-26
Abstract: The invention encompasses the novel compound of formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of formula (I).
Patent JP-4113669-B2 (JP)
IPC: C07B61/00
Filed: 1998-11-17
Granted: 2008-07-09
Abstract: The invention relates to a process for preparing dialkylphosphinate salts, which comprises a) reacting elemental yellow phosphorus with alkyl halides in the presence of alkali metal hydroxide or alkaline earth metal hydroxide to form a mixture which comprises as main constituents the salts of alkylphosphonous, phosphorous and hypophosphorous acids, b) adjusting the mixture to a pH below 7 and then reacting the mixture with olefins in the presence of a free-radical initiator and c) reacting the dialkylphosphinic acids obtained according to b) and/or alkali metal salts thereof with metal compounds of Mg, Ca, Al, Sb, Sn, Ge, Ti, Zn, Fe, Zr, Ce, Bi, Sr, Mn, Li, Na and/or K to give the metal dialkylphosphinate salts. The invention likewise relates to the use of the metal dialkylphosphinate salts prepared by the process according to the invention to prepare flame retardants.
Patent JP-4511033-B2 (JP)
IPC: C12Q1/02
Filed: 1999-04-16
Granted: 2010-07-28
Abstract: The invention relates to novel methods of detecting alterations in cell cycle regulation in a cell or a cell population and screening for agents capable of modulating cell cycle regulation through the use of multiparameter assays and a fluorescence-activated cell sorter (FACS) machine.
Patent JP-3537136-B2 (JP)
IPC: A61B5/103
Filed: 1999-09-27
Granted: 2004-06-14
Abstract: The invention relates generally to methods, systems, and devices for measuring the concentration of target analytes present in a biological system using a series of measurements obtained from a monitoring system and a Mixtures of Experts (MOE) algorithm. In one embodiment, the present invention describes a method for measuring blood glucose in a subject.
Patent JP-4143264-B2 (JP)
IPC: B60N2/08
Filed: 1999-11-05
Granted: 2008-09-03
Abstract: An automotive seat assembly (10) has a seat cushion and a seat back pivotally mounted to the seat cushion. The seat assembly includes a seat track mechanism having a lower track member (18) and an upper track member (20) supported by the lower track member (18) for movement between forward and rearward positions. An incremental locking mechanism is mounted between the upper and lower track members (18) for locking the track members in a desired position and for unlocking the track members to allow the upper track member (20) to move between the forward and rearward positions. A slide actuator is disposed adjacent the 30 locking mechanism and is moveable to an engaged position for disengaging the locking mechanism 46 and moving the upper track member (20) to a forward dump position. The seat assembly (10) also includes a positioning device which comprises a locator mounted to the upper track member (20) and moveable with the upper track member (20) as the upper track member (20) is moved to the forward dump position. The locator is interconnected to the slide actuator wherein the locator moves between a release position allowing the upper track member (20) to freely move relative to the lower track member (18) and a blocking position to align with a fixed stop which limits the movement of the upper track member (20) to a predetermined stop position upon rearward movement of the upper track member (20) from the forward dump position.
Patent JP-4510293-B2 (JP)
IPC: G10L19/005
Filed: 1999-11-12
Granted: 2010-07-21
Abstract: A method of mitigating errors in a distributed speech recognition process. The method comprises the steps of identifying a group comprising one or more vectors which have undergone a transmission error, and replacing one or more speech recognition parameters in the identified group of vectors. In one embodiment all the speech recognition parameters of each vector of the group are replaced by replacing the whole vectors, and each respective replaced whole vector is replaced by a copy of whichever of the preceding or following vector without error is closest in receipt order to the vector being replaced. In another embodiment determination of which speech recognition parameter or parameters are to be replaced is performed by predicting, from vectors received without error, a predicted value for each speech recognition parameter within said identified group of vectors, and replacing those speech recognition parameters within the identified group of vectors which are outside of a predetermined threshold relative to their respective predicted value. Also described is an apparatus for mitigating errors in a distributed speech recognition process.
Patent JP-4615736-B2 (JP)
IPC: C07K14/51
Filed: 2000-04-28
Granted: 2011-01-19
Abstract: The present invention is directed to isolated nucleic acid molecules that encode LIM mineralization protein, or LMP. The invention further provides vectors comprising nucleotide sequences that encode LMP, as well as host cells comprising those vectors. Moreover, the present invention relates to methods of inducing bone formation by transfecting osteogenic precursor cells with an isolated nucleic acid molecule comprising a nucleotide sequence encoding LIM mineralization protein. The transfection may occur ex vivo or in vivo by direct injection of virus or naked plasmid DNA. In a particular embodiment, the invention provides a method of fusing a spine by transfecting osteogenic precursor cells with an isolated nucleic acid molecule having a nucleotide sequence encoding LIM mineralization protein, admixing the transfected osteogenic precursor cells with a matrix and contacting the matrix with the spine. Finally, the invention relates to methods for inducing systemic bone formation by stable transfection of host cells with the vectors of the invention.
Patent JP-4744698-B2 (JP)
IPC: G06F3/0488
Filed: 2000-05-24
Granted: 2011-08-10
Abstract: A system for capturing an electronic message is disclosed. The system includes a printer, a sensing device and a computer system. The printer prints on a substrate user information visible to a user and coded tags invisible to the user. Each coded tag encodes an identity unique to the substrate and a location of the coded tag on the substrate. The user information defines a message area on the substrate. The sensing device senses the coded tags on the substrate when the sensing device is moved relative to the substrate. The computer system electronically captures a message composed with the sensing device via movement of the sensing device relative to the message area, the computer system using the identity of the substrate and a sequence of respective locations of coded tags sensed by the sensing device for determining the movement relative to the message area and the message.
Patent JP-5051953-B2 (JP)
IPC: B23K9/20
Filed: 2001-09-06
Granted: 2012-10-17
Abstract: A stud welding device (1) with a stud holder (3) comprising a pointed region (2) for holding a weld stud (4) and a device (5) designed as an insulating spacing means with a rim (7). The pointed region (2) of the stud holder (3) always remains behind the rim (7) of the spacing means thereby preventing electrical contact between the pointed region (2) and a component (6). The stud welding device (1) is reduced in size because it is formed without a support foot. <IMAGE>
Patent JP-4198355-B2 (JP)
IPC: H01P1/18
Filed: 2000-07-27
Granted: 2008-12-17
Abstract: An improved radio-frequency phase shift assembly includes at least one further stripline section arranged concentrically with respect to a first stripline section. Further connection lines are provided, via which an electrical connection is produced at least indirectly from the feed line to the respective tapping section associated with a stripline section. Two different pairs of antenna radiating elements can be driven with different phase angles (Phi) at mutually offset tapping points on the at least two stripline sections. The plurality of connection lines are mechanically connected to one another.
Patent JP-4082904-B2 (JP)
IPC: C01G9/03
Filed: 2000-08-24
Granted: 2008-04-30
Abstract: Ultrafine particulates of highly white zinc oxide having a reduced average particle diameter of 15 nm to 55 nm by the specific surface area as measured by the BET-one point method and that have an L value of 90 or more as measured by a Hunter-type color-difference meter. Also, a process for producing ultrafine particulates of highly white zinc oxide, comprising oxidizing zinc vapor with an oxidizing gas in a reactor, wherein a nozzle of the reactor for discharging a gas containing zinc vapor is at a temperature of 950 DEG C or more and a nozzle of the reactor for discharging the oxidizing gas is at a temperature of 900 DEG C or more, is disclosed. <IMAGE>
Patent JP-4834267-B2 (JP)
IPC: G10D1/04
Filed: 2000-08-25
Granted: 2011-12-14
Abstract: This invention relates to a lute comprising a body-shaped sound box and a neck attached thereto. The sound box is made up of a domed rear section and a cover. The aim of the invention is to provide a lute which can meet the needs of modern concert performances and be used by contemporary guitarists, whereby the excellent sound qualities of the lute are retained and the instrument can be used in a modern-day orchestra. This is achieved by providing the cover and the string-holder with a outwardly curved shape; a surface that is devoid of any transverse beams is arranged on the underside in an approximately symmetrical position with respect to the string holder and said surface is configured as a strip-free surface or fitted with strips which are symmetrical with respect to the center axis.
Patent JP-3850293-B2 (JP)
IPC: E04F13/08
Filed: 2001-01-12
Granted: 2006-11-29
Abstract: The panel element has a groove and a spring on opposite longitudinal sides, so that the groove of one element engages the spring of an adjacent element. The spring fits into the groove at an angle, so that one panel can be pivoted about the longitudinal edge of an adjacent panel. The spring and groove co-operate to secure the panel elements. The end faces of the panel elements have a groove (15b) and a tongue (16b), to connect the ends of adjacent panels. The end-side grooves and tongues can be connected by lowering one panel element onto a panel element that has already been installed, so that it cannot be lifted out.
Patent JP-4059671-B2 (JP)
IPC: A61P9/00
Filed: 2001-01-17
Granted: 2008-03-12
Abstract: Benzimidazole derivatives and analogs (I) are new. Benzimidazole derivatives and analogs of formula (I) and their salts are new. [Image] R 1, R 2H, halo, trihalomethyl, CN, OH, 1-4C alkyl or 1-4C alkoxy, or R 1+ R 2OCH 2O, OCH 2CH 2or CH 2CH 2CH 2(all optionally C-substituted by 1-4C alkyl); A : 1-7C alkylene optionally substituted by halo, OH, NO 2, CN, Alk, OAlk (2 of which may form acetal), SAlk, SO 2Alk, 1-6C acyl, 1-6C acylamino, trihalomethyl, trihalomethoxy, oxo or phenoxy (optionally substituted by halo) and optionally interrupted by O, S, SO 2or NR 3; R 3H or Alk; Alk : 1-6C alkyl; E : COOR 3, SO 3R 3, CONHR 3, SO 2NHR 3, tetrazol-5-yl, 5-oxo-1,2,4-thiadiazol-3-yl or 5-oxo-1,2,4-oxadiazol-3-yl; G : 1-6C alkylene optionally interrupted by O, S, SO 2or NR 3and optionally substituted by halo, OH, NO 2, CN, OAlk (2 of which may form acetal), trihalomethyl, trihalomethoxy, phenyl or oxo; J : 4-10 membered heteroaryl (excluding imidazole) optionally substituted by halo, OH, NO 2, CN, Alk, OAlk (2 of which may form acetal), SAlk, SOAlk, SO 2Alk, 1-6C acyl, 1-6C acylamino, optionally substituted anilido, trihalomethyl, trihalomethoxy, phenyl, oxo, COOR 3or phenoxy (optionally substituted by halo); M : a bond or S(O) m; m : 0-2, and X : CH or N. ACTIVITY : Antiinflammatory; antiallergic; respiratory; osteopathic. MECHANISM OF ACTION : Chymase inhibitor. In assays, 4-(1-((1,4-dimethylindol-3-yl)methyl)benzimidazol-2-ylthio)butanoic acid (Ia) exhibited an IC 50value for human chymase of 1-10 nM (no specific data is given). In oral bioavailability studies in rats, (Ia) at 30 mg/kg after 30 minutes and 4 hours had a blood concentrations of 16.1 and 6.3 mu g/ml, respectively.
Patent JP-4039856-B2 (JP)
IPC: C07D209/12
Filed: 2001-02-01
Granted: 2008-01-30
Abstract: The present invention provides an integrin expression inhibitor, and an agent for treating arterial sclerosis, psoriasis, cancer, retinal angiogenesis, diabetic retinopathy or inflammatory diseases, an anticoagulant, or a cancer metastasis suppressor on the basis of an integrin inhibitory action. Namely, it provides an integrin expression inhibitor comprising, as an active ingredient, a sulfonamide compound represented by the following formula (I), a pharmacologically acceptable salt thereof or a hydrate of them. <CHEM>   In the formula, B means a C6-C10 aryl ring or 6- to 10-membered heteroaryl ring which may have a substituent and in which a part of the ring may be saturated; K means a single bond, -CH=CH- or - (CR<4b>R<5b>)m<b>- (wherein R<4b> and R<5b> are the same as or different from each other and each means hydrogen atom or a C1-C4 alkyl group; and m<b> means an integer of 1 or 2); R<1> means hydrogen atom or a C1-C6 alkyl group; Z means a single bond or -CO-NH-; and R means a C6-C10 aryl ring or 6- to 10-membered heteroaryl ring which may have a substituent and in which a part of the ring may be saturated, respectively. <IMAGE>
Patent JP-4368553-B2 (JP)
IPC: C08L77/00
Filed: 2001-03-28
Granted: 2009-11-18
Abstract: Block copolymer comprising at least two kinds of polymer components each having a different structural unit in the polymer selected from polyamide, polyester, polycarbonate and polyarylate. The present block copolymer has a distinguished moldability and can be produced even from rework products or recycle products in a simple and economical manner.
Patent JP-3694268-B2 (JP)
IPC: A23K20/174
Filed: 2002-01-29
Granted: 2005-09-14
Abstract: The invention relates to a process for producing dry powders of one or more carotenoids by a) dispersing one or more carotenoids in an aqueous molecular or colloidal solution of a mixture of lactose and a protective colloid and b) converting the dispersion which has formed into a dry powder by removing the water and, where appropriate, additionally used solvents and drying, where appropriate in the presence of a coating material, wherein at least one soybean protein is used as protective colloid in process step a).
Patent JP-3853683-B2 (JP)
IPC: G01D7/00
Filed: 2002-03-25
Granted: 2006-12-06
Abstract: An indicator including a transmittable indicator panel attached to a shielding holder (a housing), and a character or a graphic form indicated inside the indicator panel. The character or the graphic form is irradiated by a light emitting diode located inside the housing. The indicator panel is formed by a character indicating part that indicates a character or a graphic form and transmits light, a masking part that intercepts light by surrounding the character indicating part, and a transmittable margin that surrounds the masking part and transmits light. With this configuration, a character or a graphic form becomes conspicuous during the daytime, and at night is never more conspicuous than is required. Thus, the visibility of the indicator can be improved. Moreover, the configuration of the transmitting light from the light source of the indicator allows it to be accommodated in the limited space available on the indicator panel.
Patent JP-4285971-B2 (JP)
IPC: C04B35/589
Filed: 2002-10-29
Granted: 2009-06-24
Abstract: Production of ceramic bearing components involves mixing the raw material to give a metal organic compound together with a chemically reactive filling material. The mixture is converted into a ceramic material by a reaction pyrolysis. <??>The raw material contains a silicon organic compound, or a polysiloxane or silicon as the preceramic stage. A metal silicide preferably ferrous silicide, is the chemically reactive filling material. The reaction pyrolysis is within a nitrogen atmosphere.
Patent JP-4386635-B2 (JP)
IPC: A61K31/506
Filed: 2001-10-26
Granted: 2009-12-16
Abstract: 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of the formula I or a pharmaceutically acceptable salt thereof can be used in the treatment of gastrointestinal stromal tumours.
Patent JP-4202135-B2 (JP)
IPC: A61P1/08
Filed: 2002-01-15
Granted: 2008-12-24
Abstract: A novel method and compositions for the local treatment of Meniere's disease, tinnitus and hearing loss are described. The treatment is based on the administration of a therapeutically effective amount of a prostaglandin of the F-type to the inner ear. The treatment can be either continuous or intermittent and may involve the use of pumps, gels, or slow release drug inserts.
Patent JP-3988682-B2 (JP)
IPC: H04L29/08
Filed: 2003-06-10
Granted: 2007-10-10
Abstract: As shown in FIG. 7, the recording medium (e.g., non-transitory computer-readable storage medium) may not only be the removable media 231 having recorded therein a program which includes a magnetic disk (including a floppy disk), an optical disc (including a CD-ROM (Compack Disk-Read Only Memory) and a DVD (Digital Versatile Disk)), a mageto-optical disc (including an MD (Mini-Disk), a semiconductor memory, etc., and is deliver to a user for providing the program independently of the main part of the apparatus, but also be the ROM 222 or a hard disk contained in the storage section 228, on which the program is recorded and which is assembled into the main apparatus beforehand so as to be provided for the user.
Patent JP-4424939-B2 (JP)
IPC: C07C7/10
Filed: 2003-08-19
Granted: 2010-03-03
Abstract: Phytosterols, squalene and Vitamin E are recovered from phytonutrients concentrate derived from crude palm oil by the disclosed invention via esterification, transesterification, vacuum distillation, saponification, crystallization and organic solvents partitioning. Crude palm oil is subjected to esterification and transesterification for the production of crude palm oil methyl esters. Phytonutrients concentrate containing phytosterols, squalene, Vitamin E and unreacted monoglycerides is recovered from crude palm oil methyl esters by multi-stages vacuum distillation in which components with higher molecular weight are filtered during second stage vacuum distillation. The purified phytonutrients concentrate is subjected to saponification process and the unsaponifiable matter is added to a combination of solvents for crystallization of phytosterols. The filtrate enriched in squalene and Vitamin E is separated to its individual squalene-rich layer and vitamin E-rich layer via organic solvents partitioning. <IMAGE>
Patent JP-4256259-B2 (JP)
IPC: A61K9/16
Filed: 2002-07-18
Granted: 2009-04-22
Abstract: Disclosed in certain embodiments is a pharmaceutical composition comprising from 10 to 40 mg of oxycodone or a pharmaceutically acceptable salt thereof and 0.65 to 0.90 mg naloxone or a pharmaceutically acceptable salt thereof.
Patent JP-4717349-B2 (JP)
IPC: A61P17/04
Filed: 2002-11-18
Granted: 2011-07-06
Abstract: The invention is directed to methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using compounds containing or based on peptides comprising a part of the amino acid sequence of a neural thread protein.
Patent JP-3994089-B2 (JP)
IPC: A61K31/16
Filed: 2002-12-11
Granted: 2007-10-17
Abstract: The invention concerns a pharmaceutical composition which contains at least panthenol and/or pantothenic acid and hyaluronic acid and/or hyaluronate and optionally additionally pharmaceutical auxiliary agents. The invention further concerns the use of the pharmaceutical composition for the treatment of ophthalmological and/or rhinological malfunctions.
Patent JP-4309289-B2 (JP)
IPC: A61B17/56
Filed: 2003-03-17
Granted: 2009-08-05
Abstract: A navigation tool for locating an axis on or in relation to which an orthopaedic surgery procedure is to be performed includes a column member having upper and lower parts. The lower part can be fastened to a bone. The upper and lower parts are connected to one another with the mating surfaces in contact with one another in such a way that the upper and lower parts can be rotated relative to one another about an axis which is perpendicular to the mating planes. The tool also includes a guide having an opening extending through it, which is fastened to the upper part of the column member so that it extends transversely relative to the upper part of the column member and can be moved relative to the upper part of the column member so as to change the distance between the opening and the point at which the guide is fastened to the upper part of the column member.
Patent JP-4463563-B2 (JP)
IPC: C08J5/04
Filed: 2003-03-10
Granted: 2010-05-19
Abstract: This invention discloses a polymeric material reinforced with single-wall nanotubes (SWNT) or multiple-wall nanotubes (MWNT) with good electrical and mechanical properties. It also discloses a process for preparing said reinforced polymeric material and their use in electrically dissipative material.